How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264 cover art

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Listen for free

View show details

About this listen

 Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.

What listeners say about How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.